These preliminary data supported the idea that DLC1 is a tumor suppressor that is silenced in meningiomas, similar to other human tumors such as nasopharyngeal, pancreatic, colon, prostate and liver cancer [4, 6, 17–19]. Here, DLC1 is linked to neoplasm.